A. Ernest Toth Jr., Chief Financial Officer at Aquestive Therapeutics, Inc. (AQST), sold 116,508 shares at $4.17 ($486K) on 2026-03-10, disclosed to the SEC on 2026-03-11.
Seasonal sale ($486k) by Chief Financial Officer — this insider has traded AQST in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 58,254 | $243K | 50.0% |
| 2 | $4.17 | 58,254 | $243K | 50.0% |
| Total | $4.17 avg | 116,508 | $486K | 100% |